The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate

Area of Science:

• Biochemistry
• Hematology
• Enzymology

Background:

• Thrombin is a key enzyme in hemostasis, responsible for converting fibrinogen to fibrin.
• Understanding factors that modulate thrombin activity is crucial for hemostasis research.

Purpose of the Study:

• To investigate the effect of 2,3-diphosphoglycerate (2,3-DPG) on thrombin's enzymatic and clotting activities.
• To elucidate the mechanism by which 2,3-DPG might interact with thrombin.

Main Methods:

• Incubation of thrombin with 2,3-DPG at a specific molar ratio.
• Assays for thrombin's clotting activity and esterase activity.
• Analysis of fibrinopeptide release and fibrin polymerization.
• Chromatographic separation of alpha-thrombin in the presence and absence of 2,3-DPG.

Main Results:

• Thrombin lost up to 70% of its clotting activity when incubated with 2,3-DPG.
• Esterase activity of thrombin remained unaffected by 2,3-DPG.
• No fibrinopeptide release was observed with thrombin in the presence of 2,3-DPG.
• Fibrin polymerization proceeded normally.
• Alpha-thrombin failed to elute from Amberlite IRC-50 chromatography in the presence of 2,3-DPG, unlike in its absence.

Conclusions:

• 2,3-diphosphoglycerate (2,3-DPG) significantly interferes with thrombin's procoagulant function, specifically its clotting activity.
• The interaction between 2,3-DPG and thrombin appears to involve the catalytic site or affect its conformation, preventing fibrinopeptide release.
• 2,3-DPG does not inhibit thrombin's esterase activity or affect downstream fibrin polymerization, indicating a specific impact on clot formation initiation.